These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Integrated backscatter for the assessment of myocardial viability. Yamada S; Komuro K Curr Opin Cardiol; 2006 Sep; 21(5):433-7. PubMed ID: 16900004 [TBL] [Abstract][Full Text] [Related]
28. [Contrast echocardiography in the assessment of left ventricular function and myocardial perfusion]. Olszowska M; Hlawaty M; Przewłocki T; Tracz W Przegl Lek; 2002; 59(7):527-9. PubMed ID: 12516243 [TBL] [Abstract][Full Text] [Related]
30. [Myocardial viability in man: state of the art and directions to pursue]. Vanoverschelde JL Bull Mem Acad R Med Belg; 1999; 154(1):91-6; discussion 96-8. PubMed ID: 10535159 [TBL] [Abstract][Full Text] [Related]
31. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability]. Vlahović A; Popović A Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679 [TBL] [Abstract][Full Text] [Related]
32. Potential clinical applications of myocardial contrast echocardiography in evaluating myocardial perfusion in coronary artery disease. Aggeli C; Bonou M; Stefanadis C Int J Cardiol; 2005 Sep; 104(1):1-9. PubMed ID: 16137502 [TBL] [Abstract][Full Text] [Related]
33. Myocardial viability assessment after acute myocardial infarction: low-dose dobutamine echocardiography versus rest-redistribution thallium-201 SPECT. Castini D; Bestetti A; Garbin M; Di Leo C; Bigi R; Sponzilli C; Concardi G; Gioventù M; Tarolo GL; Lombardi F; Fiorentini C Cardiologia; 1999 Sep; 44(9):817-23. PubMed ID: 10609391 [TBL] [Abstract][Full Text] [Related]
34. Myocardial contrast echocardiography: Role in clinical cardiology. Dwivedi G; Hayat SA; Janardhanan R; Senior R Curr Vasc Pharmacol; 2006 Jul; 4(3):229-35. PubMed ID: 16842140 [TBL] [Abstract][Full Text] [Related]
35. The complex relation between myocardial viability and functional recovery in chronic left ventricular dysfunction. Agati L; Autore C; Iacoboni C; Castaldo M; Veneroso G; Voci P; Fedele F; Dagianti A Am J Cardiol; 1998 Jun; 81(12A):33G-35G. PubMed ID: 9662225 [TBL] [Abstract][Full Text] [Related]
36. Myocardial viability in ischemic heart disease: new directions and perspectives. Previtali M Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549 [TBL] [Abstract][Full Text] [Related]
37. [Diagnostic value of stress echocardiography under dobutamine and myocardial scintigraphy for restenosis at 6 months after angioplasty of the left anterior descending artery]. Forissier JF; Maillard L; Toban P; Sirinelli A; Casset-Senon D; Eder V; Bertrand P; Pacouret G; Raynaud P; Charbonnier B Arch Mal Coeur Vaiss; 2000 Jun; 93(6):711-7. PubMed ID: 10916654 [TBL] [Abstract][Full Text] [Related]
38. Myocardial viability: magnetic resonance assessment of functional reserve and tissue characterization. Watzinger N; Saeed M; Wendland MF; Akbari H; Lund G; Higgins CB J Cardiovasc Magn Reson; 2001; 3(3):195-208. PubMed ID: 11816616 [TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging for the assessment of myocardial viability. Thomson LE; Kim RJ; Judd RM J Magn Reson Imaging; 2004 Jun; 19(6):771-88. PubMed ID: 15170783 [TBL] [Abstract][Full Text] [Related]
40. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET. Demirkol MO Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]